Author information:
(1)Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, TX 
77030, USA; Department of Molecular and Cellular Oncology, UT MD Anderson Cancer 
Center, Houston, TX 77030, USA; Department of Experimental Oncology, European 
Institute of Oncology, Milan 20139, Italy. Electronic address: 
acarugo@mdanderson.org.
(2)Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, TX 
77030, USA; Department of Molecular and Cellular Oncology, UT MD Anderson Cancer 
Center, Houston, TX 77030, USA.
(3)Institute for Applied Cancer Science, UT MD Anderson Cancer Center, Houston, 
TX 77030, USA.
(4)Department of Experimental Oncology, European Institute of Oncology, Milan 
20139, Italy.
(5)Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, TX 
77030, USA.
(6)Sheikh Ahmed Bin Zayed Al Nahyan Center for Pancreatic Cancer Research, UT MD 
Anderson Cancer Center, Houston, TX 77030, USA.
(7)Department of Epigenetics and Molecular Carcinogenesis, UT MD Anderson Cancer 
Center, Houston, TX 77030, USA.
(8)Department of Experimental Oncology, European Institute of Oncology, Milan 
20139, Italy; Department of Oncology and Hemato-oncology, University of Milan, 
Milan 20139, Italy.
(9)Center for Genomic Science of IIT@SEMM, Istituto Italiano di Tecnologia 
(IIT), Milan 20139, Italy.
(10)Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, TX 
77030, USA; Institute for Applied Cancer Science, UT MD Anderson Cancer Center, 
Houston, TX 77030, USA.
(11)Department of Surgical Oncology, UT MD Anderson Cancer Center, Houston, TX 
77030, USA.
(12)Department of Pathology, UT MD Anderson Cancer Center, Houston, TX 77030, 
USA.
(13)Department of Cancer Biology, UT MD Anderson Cancer Center, Houston, TX 
77030, USA.
(14)Department of Experimental Oncology, European Institute of Oncology, Milan 
20139, Italy. Electronic address: luisa.lanfrancone@ieo.eu.
(15)C-4 Therapeutics, Cambridge, MA 02142, USA. Electronic address: 
theffernan@c4therapeutics.com.
(16)Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, TX 
77030, USA; Institute for Applied Cancer Science, UT MD Anderson Cancer Center, 
Houston, TX 77030, USA; Department of Molecular and Cellular Oncology, UT MD 
Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: 
gdraetta@mdanderson.org.